Domani Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$532K Buy
1,549
+38
+3% +$12.8K 0.12% 70
2022
Q4
$553K Buy
1,511
+11
+0.7% +$3.9K 0.14% 67
2022
Q3
$485K Hold
1,500
0.14% 65
2022
Q2
$486K Hold
1,500
0.13% 66
2022
Q1
$430K Hold
1,500
0.09% 87
2021
Q4
$414K Hold
1,500
0.08% 87
2021
Q3
$347K Sell
1,500
-257
-15% -$63.4K 0.07% 94
2021
Q2
$403K Hold
1,757
0.08% 85
2021
Q1
$328K Hold
1,757
0.06% 100
2020
Q4
$297K Sell
1,757
-900
-34% -$134K 0.06% 101
2020
Q3
$393K Buy
2,657
+900
+51% +$139K 0.09% 81
2020
Q2
$288K Hold
1,757
0.07% 99
2020
Q1
$244K Buy
+1,757
New +$241K 0.07% 113

Other funds holding LLY

Domani Wealth's LLY Position: Q1 2023 in Review

Domani Wealth increased its Eli Lilly (LLY) stake by 2.5% in Q1 2023, buying an estimated $12.8K and bringing the position to 1,549 shares worth $532K. The position accounts for 0.12% of the portfolio, ranked #70.

Domani Wealth first reported a position in LLY in Q1 2020 and has held it in 13 quarters since. The position peaked at $553K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Domani Wealth held 1,549 shares of Eli Lilly worth $532K as of Q1 2023.
  • Domani Wealth bought 38 Eli Lilly shares in Q1 2023, an estimated $12.8K.
  • Eli Lilly made up 0.12% of Domani Wealth's portfolio in Q1 2023, its #70 holding.
  • Domani Wealth first reported a position in Eli Lilly in Q1 2020 and has held it in 13 quarters since.
  • Domani Wealth's Eli Lilly position peaked at $553K in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Domani Wealth's 13F filing for Q1 2023, filed 19 Apr 2023.